LIPO
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for Lp-310 in Oral Lichen Planus
时间：2025-02-06 19:00:00 市场： 美股
Spartan Capital Securities, Llc Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $875,500 Private Placement
时间：2025-01-11 02:24:38 市场： 美股 综合
Lipella Pharmaceuticals Inc - Reverse Stock Split to Comply With Nasdaq Minimum Bid Price Requirement
时间：2024-11-02 04:30:00 市场： 美股 综合
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of Lp-310 for Oral Lichen Planus
时间：2024-09-24 20:00:02 市场： 美股 综合